The present study investigated the role that imaging could have for assessing lung inflammation in a mouse model of HDM (house dust mite)-provoked allergic inflammation. Inflammation is usually assessed using terminal procedures such as BAL (bronchoalveolar lavage) and histopathology; however, MRI (magnetic resonance imaging) and CT (computed tomography) methods have the potential to allow longitudinal, repeated study of individual animals. Female BALB/c mice were administered daily either saline, or a solution of mixed HDM proteins sufficient to deliver a dose of 12 or 25 μg total HDM protein±budesonide (1 mg/kg of body weight, during weeks 5–7) for 7 weeks. AHR (airway hyper-responsiveness) and IgE measurements were taken on weeks 3, 5 and 7. Following imaging sessions at weeks 3, 5 and 7 lungs were prepared for histology. BAL samples were taken at week 7 and lungs prepared for histology. MRI showed a gradual weekly increase in LTI (lung tissue intensity) in animals treated with HDM compared with control. The 25 μg HDM group showed a continual significant increase in LTI between weeks 3 and 7, the 12 μg HDM-treated group showed a similar rate of increase, and plateaued by week 5. A corresponding increase in AHR, cell counts and IgE were observed. CT showed significant increases in lung tissue density from week 1 of HDM exposure and this was maintained throughout the 7 weeks. Budesonide treatment reversed the increase in tissue density. MRI and CT therefore provide non-invasive sensitive methods for longitudinally assessing lung inflammation. Lung tissue changes could be compared directly with the classical functional and inflammatory readouts, allowing more accurate assessments to be made within each animal and providing a clinically translatable approach.
Skip Nav Destination
Article navigation
Research Article|
August 02 2013
Longitudinal characterization of a model of chronic allergic lung inflammation in mice using imaging, functional and immunological methods
Kumar Changani;
*Respiratory Therapeutic Area, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
†Platform Technology and Science, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
Correspondence: Dr Kumar Changani (email [email protected]).
Search for other works by this author on:
Catherine Pereira;
Catherine Pereira
‡AstraZeneca, Alderley Park, Macclesfield SK10 4TG, U.K.
Search for other works by this author on:
Simon Young;
Simon Young
‡AstraZeneca, Alderley Park, Macclesfield SK10 4TG, U.K.
Search for other works by this author on:
Robert Shaw;
Robert Shaw
*Respiratory Therapeutic Area, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
Search for other works by this author on:
Simon P. Campbell;
Simon P. Campbell
*Respiratory Therapeutic Area, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
†Platform Technology and Science, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
Search for other works by this author on:
Kashmira Pindoria;
Kashmira Pindoria
*Respiratory Therapeutic Area, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
†Platform Technology and Science, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
Search for other works by this author on:
Steve Jordan;
Steve Jordan
‡AstraZeneca, Alderley Park, Macclesfield SK10 4TG, U.K.
Search for other works by this author on:
Katherine Wiley;
Katherine Wiley
‡AstraZeneca, Alderley Park, Macclesfield SK10 4TG, U.K.
Search for other works by this author on:
Sarah Bolton;
Sarah Bolton
‡AstraZeneca, Alderley Park, Macclesfield SK10 4TG, U.K.
Search for other works by this author on:
Tony Nials;
Tony Nials
*Respiratory Therapeutic Area, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
Search for other works by this author on:
Michael Haase;
Michael Haase
*Respiratory Therapeutic Area, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
†Platform Technology and Science, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
Search for other works by this author on:
Mike Pedrick;
Mike Pedrick
†Platform Technology and Science, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
Search for other works by this author on:
Richard Knowles
on behalf of the U-BIOPRED Consortium
Richard Knowles
*Respiratory Therapeutic Area, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
§Arachos Pharma, Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2FX, U.K.
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
February 28 2013
Revision Received:
May 17 2013
Accepted:
May 31 2013
Accepted Manuscript online:
May 31 2013
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© The Authors Journal compilation © 2013 Biochemical Society
2013
Clin Sci (Lond) (2013) 125 (12): 555–564.
Article history
Received:
February 28 2013
Revision Received:
May 17 2013
Accepted:
May 31 2013
Accepted Manuscript online:
May 31 2013
Citation
Kumar Changani, Catherine Pereira, Simon Young, Robert Shaw, Simon P. Campbell, Kashmira Pindoria, Steve Jordan, Katherine Wiley, Sarah Bolton, Tony Nials, Michael Haase, Mike Pedrick, Richard Knowles; on behalf of the U-BIOPRED Consortium, Longitudinal characterization of a model of chronic allergic lung inflammation in mice using imaging, functional and immunological methods. Clin Sci (Lond) 1 December 2013; 125 (12): 555–564. doi: https://doi.org/10.1042/CS20130086
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.